Outcome study design

Appropriate study design should be selected to achieve the desired outcome. A description of the type/design of frial to be conducted (e.g., double-blind, placebo-controlled, parallel design) and a schematic diagram of trial design. 

Biopharmaceutical issues to be addressed will include a discussion of the pharmaceutical development process as it relates to in vivo and in vitro performance and the general approach taken concerning bioavailability, bioequivalence, and in vitro dissolution profiles. There should be a comparative analysis of relevant studies—objectives, study design, conduct, outcome, and data analyses. The effects of formulation changes (including different strengths of product and... 

Based on four key elements (study design, study quality, consistency and directness) the system grades the evidences for each main outcome into four categories (high, moderate, low and very low) dependent on the quality of the evidences. Limitations in study quality, important inconsistency of results, or uncertainty about the directness of the evidence can lower the grade of evidence. Essentials in process, criteria and grading in the GRADE system is presented in Box 3.5. 

Study Design Treatment, randomized, open label, active control, parallel assignment, safety/efficacy study Official Title A Phase III, Randomized, Open-Label Study of Lopina-vir/Ritonavir Tablets 800/200mg Once-Daily Versus 400/100mg Twice-Daily When Co-administered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced, HIV-1 Infected Subjects Primary Outcome Measures ... 

Statistical analysis of fetal and neonatal data should be conducted with careful consideration of study design, the endpoint under consideration, sample size, effects of gender, and the influence of litter on analytical outcome. It is critical that litter-mates not be treated as independent observations in the statistical analysis (13). 

Generic instruments apply to a wide variety of patients. Their broad applicability is derived from their coverage of the complete spectrum of function, disability, and distress that is relevant to HRQL. They are designed for use in a wide variety of conditions, but they may not focus on aspects of HRQL that are of interest to the investigator and may be unresponsive to small but clinically important changes. Some examples of generic instruments are the Sickness Impact Profile and the Medical Outcomes Study Short Forms 36 and 12 (SF-36 and SF-12) (Ware, 1991). 

Example Reference(s) Objective Study design/Duration Assay Outcome... 

---